SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-040044
Filing Date
2019-11-05
Accepted
2019-11-05 06:30:36
Documents
14
Period of Report
2019-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K amrn-8k_20191105.htm   iXBRL 8-K 38945
2 EX-99.1 amrn-ex991_6.htm EX-99.1 571548
3 GRAPHIC go3blp2t3aj5000001.jpg GRAPHIC 4897
  Complete submission text file 0001564590-19-040044.txt   779544

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA amrn-20191105.xsd EX-101.SCH 5976
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE amrn-20191105_lab.xml EX-101.LAB 19384
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amrn-20191105_pre.xml EX-101.PRE 11600
12 EXTRACTED XBRL INSTANCE DOCUMENT amrn-8k_20191105_htm.xml XML 3634
Mailing Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000
Business Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21392 | Film No.: 191191656
SIC: 2834 Pharmaceutical Preparations